摘要
目的观察卡马西平辅助治疗肠易激综合征的临床疗效。方法100例患者随机分组,50例给予卡马西平片辅助常规治疗,50例给予常规治疗,均治疗8周后进行疗效判断。结果治疗组:显效36例,有效9例,无效5例;对照组:显效21例,有效22例,无效7例。两组对比,差异有统计学意义(P<0.05)。结论卡马西平辅助治疗组比对照组治疗肠易激综合征疗效好。
Objective To observe the clinical efficacy of carbamazepinein the supplementary treatment of irritable bowel syndrome. Methods 100 cases were randomly divided into two groups. 50 cases in the treatment group were given carbamazepine as the supplement of conventional treatment and the other 50 cases in the control group were given the conventional treatment. The therapeutic effect was evaluated after 8 weeks of treatment. Results In the treatment group： markedly effective in 36 cases, effective in 9 cases and invalid 5 cases; in the control group： markedly effective in 21 cases,effective in 22 cases and invalid 7 cases. Compare the two groups, the difference had statistical significance（P〈0. 05）. Conclusion Carbamazepine adjuvant therapy group has better therapeutic effect than the control group for treating irritable bowel syndrome.
出处
《检验医学与临床》
CAS
2009年第9期686-687,共2页
Laboratory Medicine and Clinic
关键词
卡马西平
肠易激综合征
疗效分析
carbamazepine
irritable bowel syndrome
efficacy analysis
